SPECNOVA LLC   Report issue

For profit Phase 1
Founded: Wilmington DE United States (2017)
Status: No NME R&D (2017)

Organization Overview

First Clinical Trial
2017
NCT03528538
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Specnova, inc | SPECNOVA LLC